Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Argent Biopharma ( (AU:RGT) ) has issued an announcement.
Argent Biopharma Ltd has announced an addendum to its Notice of Annual General Meeting, scheduled for November 28, 2025. The addendum includes new resolutions regarding the issuance and amendment of convertible notes and options, aimed at enhancing the company’s financial flexibility and investment appeal. Shareholders are advised on the procedures for voting on these additional resolutions, which could potentially impact the company’s capital structure and stakeholder interests.
More about Argent Biopharma
YTD Price Performance: -55.29%
Average Trading Volume: 122,137
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.91M
Learn more about RGT stock on TipRanks’ Stock Analysis page.

